Takeda shares positive Phase IIIb data; NIA grant for Phase II study on new oral Alzheimer's treatment - Endpoints News https://t.co/qtccKEL7uM
— IDRO (@IDROOhio) May 20, 2019
from Twitter https://twitter.com/IDROOhio
May 20, 2019 at 08:32AM
Monday, May 20, 2019
Takeda shares positive Phase IIIb data; NIA grant for Phase II study on new oral Alzheimer's treatment - Endpoints News https://t.co/qtccKEL7uM
from Twitter https://twitter.com/IDROOhio
May 20, 2019 at 08:32AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment